BACR Executive

The Executive Committee is comprised of 3 Officers; Chairman, Honorary Secretary, Honorary Treasurer and 9 ordinary members. Election to the Executive takes place at the Annual General Business Meeting each year.


The Executive Committee is responsible for ensuring that the aims/objectives of the Association, as set out in the Constitution (available on request to the Secretariat) are met.

The aims are achieved by the organisation of scientific meetings/conferences and workshops as reflected by the diverse interests of the membership; by the awarding of funds to its members to promote scientific exchange of research between individuals and/or research groups and to support attendance/presentation at other scientific meetings of interest and relevance. These activities comply with the educational remit encompassed in the Constitution.

As Trustees of a registered charity it is also the responsibility of the members of the Executive Committee to ensure the proper financial management of the Association and its accounts.

More info

BACR Officers


holder

Margaret C Frame PhD FRSE FMedSci

President

Margaret Frame is a research scientist with interests in novel cancer mechanisms, as evidenced by deep biology, imaging and new approaches to drug discovery and cancer therapeutics – work that has been funded by five successive CRUK (or predecessor charity) Programme grants and more recently also by an ERC Advanced Investigator Grant.

From 2002-2007, Margaret was Deputy Director of the core funded CRUK Beatson Institute for Cancer Research in Glasgow, after which she moved to the University of Edinburgh (UoE). Currently she is Professor of Cancer Research and co-director of the CRUK Edinburgh Centre. Margaret is very active in supporting the scientific careers of early- and mid-stage researchers, both clinical and non-clinical, an interest that stems from her time as Chairman of the CRUK New Investigator Panel and from her own experiences when building a research career during the ‘young family’ years. As Director-elect of the MRC-IGMM (Institute of Genetics and Molecular Medicine) in Edinburgh, Margaret also intends to promote a strong translational agenda with innovative twists, including new approaches to biology-led drug discovery and translation of genetics and genomics to the NHS.

In regard of personal achievements, Margaret was awarded the Tenovus Medal in 1999, and was elected a Fellow of the Royal Society of Edinburgh in 2002, an EMBO Member in 2007 and a Fellow of the Academy of Medical Sciences in 2009. Very recently, she was delighted to be awarded the Chancellor’s prize for Research - presented by HRH The Princess Royal (the Chancellor of the University of Edinburgh). In January this year, she took up the role as President of the British Association for Cancer Research.

More info
holder

Professor Michelle Garrett

Honorary Secretary

Michelle Garrett is Professor of Cancer Therapeutics in the School of Biosciences at the University of Kent, Canterbury, UK and visiting Professor of Cancer Therapeutics at The Institute of Cancer Research, London, UK.

Michelle received her undergraduate degree from the University of Leeds and then joined The Institute of Cancer Research (ICR) London, to undertake her PhD research with Alan Hall on the RhoA small GTPase. After gaining her PhD in cancer cell signalling, Michelle won a Lucille Markey International Research Fellowship and in 1991 moved to the USA to undertake post-doctoral studies at Yale University School of Medicine on regulation of small GTPases in the yeast Saccharomyces cerevisiae, with Peter Novick.

In 1994 Michelle moved from Yale to join Onyx Pharmaceuticals, California, USA, where she went on to become a team leader involved in the development of cancer drugs targeting the cell division cycle. She then returned to the ICR in 1999 to take up a team leader position in the Cancer Research UK Cancer Therapeutics Unit, where her research specialised in the discovery and development of novel small molecule therapeutics for the treatment of cancer. Whilst at the ICR, Michelle became a Reader in Cancer Therapeutics and Head of Biology for the CRUK Cancer Therapeutics Unit. Michelle was also a member of the joint ICR/Royal Marsden interdisciplinary team, which in 2012 won the prestigious AACR Team Science award. In September 2014 Michelle joined the School of Biosciences at the University of Kent and currently has two cancer drugs in the clinic.

More info
holder

Professor Julian Downward

Chair

Julian Downward carried out post-graduate work at the Imperial Cancer Research Fund in London with Mike Waterfield and post-doctoral work at the Massachusetts Institute of Technology with Robert Weinberg before setting up his own lab in 1989 ...

at the Imperial Cancer Research Fund, which subsequently became the Cancer Research UK London Research Institute and now the Francis Crick Institute. He is Associate Research Director of the Francis Crick Institute. His work focuses on the role played by major oncogenes such as RAS and EGFR in human cancer. He established that EGFR is the product of the erbB proto-oncogene and was responsible for mapping out the signaling pathways linking EGFR to RAS and downstream of RAS to the MAP kinase and PI 3-kinase pathways. More recently he has worked on finding novel approaches to targeting RAS mutant lung cancers, including through exploiting synthetic lethality and also understanding effects of RAS signaling on suppression of the immune system’s response to the tumour. Julian is a Fellow of the Royal Society, a Fellow of the Academy of Medical Sciences and a Member of the European Molecular Biology Organisation.

More info
holder

Amanda Harvey

Honorary Treasurer

Following post-doctoral research at the University of Sheffield and Royal Holloway, University of London, Amanda joined Brunel in 2006 to further develop her research interests in breast cancer.

Her research focuses on cell signalling pathways and their roles in mediating tumour-like behaviour, as well as their contribution to therapeutic drug resistance. Current projects are involve investigating the roles of breast tumour kinase (Brk) in cell responses to chemo- and radio-therapy, understanding the mechanisms behind everolimus resistance, and the part that 1q genes/proteins such as ACBD3 and PI4K play in breast cancer cell biology. In addition, she has research interests in the potential of plant extracts as novel anti-tumour agents.

Amanda has served on the Breast Cancer Campaign Scientific Advisory Board, and joined the British Association for Cancer Research (BACR) Executive Committee in 2016 becoming Treasurer in 2017.

More info

BACR Executive Committee
November 2017 – November 2018


Post Member
President Professor Margaret Frame
Edinburgh Cancer Research Centre

University of Edinburgh
Western General Hospital
Crewe Road South
EH4 2XR

e-mail: m.frame@ed.ac.uk
Vice-Presidents Dr J S Howell
Pathology Department

Poole General Hospital
Poole, Dorset



Dr Michael Moore

Dr Anne Simmonds-Walder
3 Links Road

Canford Cliffs
Poole, Dorset
BH14 9QP



Chair Professor Julian Downward
Francis Crick Institute, London

44 Lincoln's Inn Fields
London WC2A 3LY, UK.

e-mail: Julian.downward@crick.ac.uk
Secretary Professor Michelle Garrett
University of Kent

School of Biosciences
Canterbury
CT2 7NJ

e-mail: m.d.garrett@kent.ac.uk
Secretary Elect Prof Valerie Speirs
LICAP

University of Leeds
Wellcome Brenner Building
St James’s University Hospital
Leeds LS9 7TF

e-mail: v.speirs@leeds.ac.uk
Treasurer Dr Amanda Harvey
Brunel University

Biosciences
Kingston Lane
Uxbridge
B8 3HP

e-mail: amanda.harvey@brunel.ac.uk
Member Prof Richard Bayliss
University of Leeds

Astbury 6.108a
School of Molecular and Cellular Biology
University of Leeds
LS2 9UT

e-mail: richard.bayliss@leeds.ac.uk
Member Dr Charlotte Bevan
Imperial College London

Department of Oncology
Hammersmith Hospital Campus
Du Cane Road
London W12 0NN

e-mail: charlotte.bevan@imperial.ac.uk
Member Prof Barry Davies
AstraZeneca

Imed Oncology
Darwin Building (Unit 310)
Cambridge
CB4 0WG

e-mail: barry.davies@astrazeneca.com
Member Prof Anna Grabowska
University of Nottingham

D Floor, West Block
Queen’s Medical Centre
Nottingham
NG7 2UH

e-mail: anna.grabowska@nottingham.ac.uk
Member Dr Sarah Holt
Cancer Research UK Centre for Drug Development

Portway Building
Granta Park
Cambridge
CB21 6GS

e-mail: sarah.holt@cancer.org.uk
Member Dr Craig Murdoch
University of Sheffield

Dept of Oral & Maxillofacial Medicine
School of Clinical Dentistry
Claremont Crescent
Sheffield S10 2TA

e-mail: c.murdoch@sheffield.ac.uk
Member Dr Claire Perks
University of Bristol

Department of Surgery
Level 7
Bristol Royal Infirmary
Bristol BS2 8HW

e-mail: claire.m.perks@bristol.ac.uk
Member Dr Isabel Pires
University of Hull

School of Biological, Biomedical and Environmental Sciences
Hardy Building
Cottingham Road
Hull
HU6 7RX

e-mail: i.pires@hull.ac.uk
Member Professor Kevin Ryan
Cancer Research UK Beatson Institute

Tumour Cell Death Laboratory
Garscube Estate
Switchback Road
Glasgow
G61 1BD

e-mail: k.ryan@beatson.gla.ac.uk
Member Dr Sarah Storr
Molecular Therapeutics and Formulation

University of Nottingham
School of Pharmacy
Academic Oncology
Nottingham City Hospital
Nottingham
NG5 1PB

e-mail: sarah.storr@nottingham.ac.uk
Co-opted Member David Scott
CRUK

Angel Building
407 St John Street
London
EV1V 4AD

e-mail: david.scott@cancer.org.uk
Co-opted Member Robert Wilkinson
MedImmune

Aaron Klug Building
Granta Park
Cambridge
CB21 6HG

e-mail: wilkinsonr@medImmune.com
Co-opted Student Member Sophie Roberts
LICAP

Wellcome Trust Brenner Building
University of Leeds
St James’s University Hospital
Beckett Street
Leeds
LS9 7FT

e-mail: bs13s3r@leeds.ac.uk

BACR Committee
November 2015 – November 2016


Member
Dr Richard Bayliss
University of Leicester

Department of Biochemistry
Henry Wellcome Building
Lancaster Road
Leicester
LE1 9HN

e-mail: r.w.bayliss@leeds.ac.uk
Dr Charlotte Bevan
Imperial College London

Department of Oncology
Hammersmith Hospital Campus
Du Cane Road
London
W12 0NN

e-mail: charlotte.bevan@imperial.ac.uk
Dr Amanda Harvey
Brunel University

Biosciences
Kingston Lane
Uxbridge
B8 3HP

e-mail: amanda.harvey@brunel.ac.uk
Dr Penelope Ottewell
University of Sheffield

Oncology
Beech Hill Road
Sheffield
S10 2RX

e-mail: p.d.ottewell@sheffield.ac.uk
Dr Claire Perks
University of Bristol

Department of Surgery
Level 7
Bristol Royal Infirmary
Bristol
BS2 8HW

e-mail: claire.m.perks@bristol.ac.uk
Dr Isabel Pires
University of Hull

School of Biological, Biomedical and Environmental Sciences
Hardy Building
Cottingham Road
Hull
HU6 7RX

e-mail: i.pires@hull.ac.uk
Professor Catrin Pritchard
Department of Biochemistry

University of Leicester
Lancaster Road
Leicester
LE1 9HN

e-mail: cap8@le.ac.uk
Professor Charles Swanton
CRUK London Research Institute

Translational Cancer Therapeutics Laboratory
44 Lincoln's Inn Fields
London
WC2A 3LY

e-mail: charles.swanton@cancer.org.uk
Professor Anna Grabowska
University of Nottingham

Division of Pre-Clinical Oncology

Queen's Medical Centre

Nottingham

NG7 2UH

e-mail: Anna.Grabowska@nottingham.ac.uk